Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) For Lupkynis® (Voclosporin) In Japan
ROCKVILLE, Md. & EDMONTON, AB — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announced that the Company’s collaboration partner, Otsuka Pharmaceutical Ltd., filed a new drug application (NDA)… Read More




